These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20205614)

  • 1. Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?
    Grauslund J; Rasmussen LM; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Apr; 70(3):188-93. PubMed ID: 20205614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.
    Grauslund J; Nybo M; Green A; Sjølie AK
    Scand J Clin Lab Invest; 2010 Oct; 70(6):392-8. PubMed ID: 20575653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus.
    Tavintharan S; Pek LT; Liu JJ; Ng XW; Yeoh LY; Su Chi L; Chee Fang S
    Diab Vasc Dis Res; 2014 Sep; 11(5):359-62. PubMed ID: 25005034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients.
    Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM
    Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.
    Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ
    Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.
    Blindbæk SL; Schlosser A; Green A; Holmskov U; Sorensen GL; Grauslund J
    Acta Diabetol; 2017 Apr; 54(4):367-372. PubMed ID: 28039584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH; Elhenawy YI; Nawar MM
    J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy.
    Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M
    Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.
    Blázquez-Medela AM; García-Ortiz L; Gómez-Marcos MA; Recio-Rodriguez JI; Sánchez-Rodríguez A; López-Novoa JM; Martínez-Salgado C
    Eur J Clin Invest; 2012 May; 42(5):548-56. PubMed ID: 22050177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS; Chaturvedi N; Teerlink T; Idzior-Walus B; Fuller JH; Stehouwer CD;
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients.
    Xiang GD; Sun HL; Zhao LS
    Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women.
    Nabipour I; Kalantarhormozi M; Larijani B; Assadi M; Sanjdideh Z
    Metabolism; 2010 May; 59(5):742-7. PubMed ID: 19922962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus.
    Guzel S; Seven A; Kocaoglu A; Ilk B; Guzel EC; Saracoglu GV; Celebi A
    Diab Vasc Dis Res; 2013 Jan; 10(1):25-31. PubMed ID: 22496403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications.
    Chandy A; Pawar B; John M; Isaac R
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):924-8. PubMed ID: 18974577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher concentrations of osteoprotegerin in type 1 diabetic patients are related to retinopathy: Results from the Poznań Prospective Study.
    Grzelka A; Naskręt D; Araszkiewicz A; Uruska A; Wegner M; Zozulińska-Ziółkiewicz D
    Adv Clin Exp Med; 2017 Dec; 26(9):1343-1349. PubMed ID: 29442454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.